Abera Bioscience AB (NGM:ABERA)
6.76
-0.06 (-0.88%)
At close: Apr 28, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 138.57 million as of April 28, 2026. Its market cap has increased by 58.91% in one year.
Market Cap
138.57M
Enterprise Value
115.08M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.76
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 138.57M, an increase of 19.89%. That is a compound annual growth rate of 3.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 138.57M | 10.47% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aquaticus Real Estate AB | 139.22M |
| Crown Energy AB | 134.60M |
| Eurobattery Minerals AB | 145.46M |
| Solution International Nordics AB | 148.37M |
| Seamless Distribution Systems AB | 150.27M |
| Nowonomics AB | 125.40M |
| Fable Media Group AB | 171.21M |
| Railway Metrics and Dynamics Sweden AB | 110.46M |